![Michael Schultz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Michael Schultz served as a Member-Supervisory Board at MOLOGEN AG from 2018 to 2020.
He also worked as the President & Chief Scientific Officer at Chembridge Research Laboratories, Inc.
Anciens postes connus de Michael Schultz
| Sociétés | Poste | Fin |
|---|---|---|
| MOLOGEN AG | Directeur/Membre du Conseil | 30/07/2020 |
Chembridge Research Laboratories, Inc.
 Chembridge Research Laboratories, Inc. Medical DistributorsDistribution Services Discovers molecule drugs | President | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
MOLOGEN AG
 MOLOGEN AG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for the treatment of infectious diseases | Health Technology |
Chembridge Research Laboratories, Inc.
Chembridge Research Laboratories, Inc. Medical DistributorsDistribution Services Discovers molecule drugs | Distribution Services |
